Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk
Patient Information Leaflet last updated on the eMC: 06/11/2009
PIL Femodene

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/06/2008 and displayed until 06/11/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 15/09/2006 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 17/03/2005 and displayed until 15/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/02/2005 and displayed until 17/03/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change from the BAN of the active substance to the rINN
Updated on 22/10/2002 and displayed until 25/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 11/01/2002 and displayed until 22/10/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 12/09/2000 and displayed until 11/01/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/07/2000 and displayed until 12/09/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 15/03/2000 and displayed until 06/07/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ethinylestradiol
   gestodene


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk